This HTML5 document contains 127 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q54539420
rdf:type
wikibase:Item
schema:description
artigo científico (publicado na 2011) artículo científico publicado en 2011 article científic บทความทางวิทยาศาสตร์ videnskabelig artikel (udgivet 2011) naučni članak vitskapeleg artikkel գիտական հոդված article scientifique (publié 2011) 2011年学术文章 vedecký článok наукова стаття, опублікована в грудні 2011 teaduslik artikkel artikulong pang-agham επιστημονικό άρθρο 2011年學術文章 artículu científicu 2011年學術文章 2011年学术文章 ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ مقالة علمية articol științific научная статья 2011年學術文章 artigo científico (publicado na 2011) 2011년 논문 vědecký článek scientific article 2011年学术文章 2011年の論文 2011年学术文章 vetenskaplig artikel tieteellinen artikkeli سائنسی مضمون научни чланак мақолаи илмӣ wetenschappelijk artikel 2011年學術文章 articolo scientifico artigo científico scienca artikolo bài báo khoa học სამეცნიერო სტატია מאמר מדעי 2011 nî lūn-bûn wissenschaftlicher Artikel artykuł naukowy artikull shkencor bilimsel makale 2011年學術文章 مقالهٔ علمی научна статия vitenskapelig artikkel mokslinis straipsnis 2011年学术文章 мақолаи илмӣ 2011年學術文章 tudományos cikk научни чланак article scientific
p:P577
wds:Q54539420-449216F3-062C-4967-9E80-A561971B11DE
wdt:P577
2011-12-30T00:00:00Z
p:P2093
wds:Q54539420-EF7D9467-469E-4659-BB54-4A7D355ABD5E wds:Q54539420-E6871591-43B4-4722-A89D-50337BA2243B wds:Q54539420-CD3C0242-9E6A-4017-928E-36D161785C97 wds:Q54539420-ABD9DA51-17DD-47AB-AE87-0F132A984019 wds:Q54539420-8BF3C101-7A58-4854-9A73-951C2465E3B9 wds:Q54539420-8D930A08-4C44-46B1-9424-F6B7D38CE5CD wds:Q54539420-71DEF8DB-9AF8-4F5E-8D52-BC6644D68157 wds:Q54539420-68B0C59B-8613-4FB7-80F7-2C3320470AE9 wds:Q54539420-4EB02BE6-DEB1-4910-BCB8-74D3F5435E29 wds:Q54539420-3D22BFD5-CF68-4A3C-9E58-F3E0F5138D04 wds:Q54539420-259D1386-9BB7-4F27-8FB5-876772D8D09E
wdt:P2093
E Calvo R A Figlin S Bracarda V Grünwald B Escudier O Anak T E Hutson J A Thompson S Oudard D Kim A Panneerselvam
rdfs:label
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study. Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study.
skos:prefLabel
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study. Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study.
schema:name
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study. Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study.
p:P50
wds:Q54539420-4A5F5916-0A8F-4E72-B8FD-EF6DC66BBD17 wds:Q54539420-6EA2E8F8-7D68-445B-9A47-1B86E13DDBAF wds:Q54539420-6AE5967C-0557-47F6-BB72-2CF77331CA8C
wdt:P50
wd:Q42721742 wd:Q56548743 wd:Q37393105
p:P1476
wds:Q54539420-EB2D7F23-8B26-47BF-BF9E-8B4CFBD7DBE0
wdt:P1476
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study
p:P304
wds:Q54539420-E973A537-4D16-4E3B-960F-BF31C3C04700
wdt:P304
333-339
p:P31
wds:Q54539420-59038579-E798-43CC-9A4B-883E29FB9A11
wdt:P31
wd:Q13442814
p:P921
wds:Q54539420-52864FCA-F8F0-47B3-AF30-3A716BD6C8C4 wds:Q54539420-D3488AFC-6DBB-4E51-A4B9-718663290FBD wds:Q54539420-A8E9535D-4827-43DC-A142-3D40FBEB8CFE wds:Q54539420-F44BBA35-1E24-4AC0-BE08-78C7B1486DA0
wdt:P921
wd:Q181600 wd:Q111140 wd:Q1164529 wd:Q19000948
p:P698
wds:Q54539420-F4E021F4-7B14-4BE5-931C-EDA37F55EFDD
wdtn:P698
n9:22209391
wdt:P698
22209391
p:P1433
wds:Q54539420-39F0F316-58B5-45D2-BFAA-DE8E48AD6792
wdt:P1433
wd:Q332260
p:P433
wds:Q54539420-AA7AC209-CEE5-4C4B-B1DA-6754E4DD8864
p:P478
wds:Q54539420-4328227E-56E2-4BEC-83C5-78DB1E0EF7F8
wdt:P433
3
wdt:P478
48
p:P356
wds:Q54539420-18985FF2-CC02-4352-9B8B-D7859DF8BF2B
wdtn:P356
n12:J.EJCA.2011.11.027
wdt:P356
10.1016/J.EJCA.2011.11.027
p:P8608
wds:Q54539420-5F71C9D6-140D-4093-98CF-8E2BBC0EB6F2
wdt:P8608
release_kg5ifz2oqrdhjicyfs7iuonydi
p:P5875
wds:Q54539420-AD7D05ED-6B5E-4701-96F8-8C99690F97F0
wdt:P5875
51972728